Grantees

RCORP-Implementation will advance RCORP’s overall goal by strengthening and expanding SUD/OUD prevention, treatment, and recovery service delivery in high-risk rural communities. By expanding the options for SUD/OUD services across the care spectrum, RCORP-Implementation will help rural residents access treatment and move towards recovery.

Visit HRSA for more information about these grant programs.

Browse Implementation I grantees here.
Browse Implementation II grantees here.
Browse Implementation III grantees here.

RCORP-Medication Assisted Treatment Expansion (RCORP-MAT Expansion), will advance RCORP’s overall goal by establishing and/or expanding MAT in eligible hospitals, health clinics, or tribal organizations in high-risk rural communities. RCORP-MAT Expansion aims to increase the number of access points where individuals living in rural communities with OUD can receive evidence-based treatment. Additionally, recognizing that MAT patients may have other clinical and social service needs, RCORP-MAT Expansion requires that eligible entities provide and/or coordinate complementary services.

Visit HRSA for more information about these grantee programs.

Browse MAT Expansion grantees here.

The purpose of RCORP-NAS is to reduce the incidence and impact of Neonatal Abstinence Syndrome (NAS) in rural communities by improving systems of care, family supports, and social determinants of health.

While the focus of RCORP-NAS is primarily opioid use disorder (OUD), grantees may also choose to address additional substances of concern or substance use disorders (SUDs) among the target population. The target population is pregnant women, mothers, and women of childbearing age who have a history of, or who are at risk for, SUD/OUD and their children, families, and caregivers who reside in rural areas.

Visit HRSA for more information about these grantee programs.

Browse NAS grantees here.

RCORP-Psychostimulant Support aims to strengthen and expand prevention, treatment, and recovery services for individuals in rural areas who misuse psychostimulants. The primary focus of this program is psychostimulant misuse and use disorders. However, recognizing that many individuals who misuse psychostimulants may misuse multiple substances, or have other co-occurring conditions, grantees may help address other SUD-related needs of the target population of individuals, families, and other community members affected by psychostimulant use disorders.

Additionally, award recipients will develop a Mental/Behavioral Health Disparities Impact Statement to reduce health disparities in the target rural service area during and beyond the period of performance.

Visit HRSA for more information about these grantee programs.

Browse Psychostimulant Support I grantees here.

Browse Psychostimulant Support II grantees here.